论文部分内容阅读
随着肥胖和代谢综合征在全球流行,非酒精性脂肪性肝病(NAFLD)增长迅速,近年来新的诊断方法,特别是影像学等无创性诊断方法不断提出,为NAFLD的临床提供了很大帮助,但仍然不能取代肝活检在其诊断中的重要地位;同时NAFLD的治疗也有很大进展,在改变生活方式的基础上包括胰岛素增敏剂、降脂药、血管紧张素转换酶抑制剂等药物的应用,为NAFLD的治疗提供了新的方法,但其疗效仍需要进一步的临床观察。
With the prevalence of obesity and metabolic syndrome in the world, non-alcoholic fatty liver disease (NAFLD) is growing rapidly. In recent years, new diagnostic methods, especially noninvasive diagnostic methods such as imaging, have been put forward to provide large clinical coverage for NAFLD Help, but still can not replace the importance of liver biopsy in its diagnosis; the same time NAFLD treatment has also made great progress in changing the lifestyle based on including insulin sensitizers, lipid-lowering drugs, angiotensin-converting enzyme inhibitors The application of the drug provides a new method for the treatment of NAFLD, but its efficacy still needs further clinical observation.